Patents for Chris Southan

 

These 22 entries are non-redundant i.e. there are 34 entries in the EBI Patent Abstracts database because some applications have published in more than one national office. Patent numbers are linked to CiteXplore entries which in turn link to European Patent Office esp@cenet. The ten entries marked with [*] have been granted after examination by the United States Patent & Trademark Office. Names given in brackets are the eventual HGNC approved symbols and gene names for these claimed sequences. Where available, nucleotide entries from the patent division of GenBank are included and the equivalent EMBL-Bank links are in the CiteXplore entries.  

 

[22] Larminie C D., Southan C.D., Rance K., & Hayes P.D. Heparanase-like Endoglycosidase (HPSE2, heparanase 2)  12-June-2000,  GB2367059 published 27-Mar-2002 .

 

[21]  Lonetto,M.A., Zhu,Y., Li,X. & Southan,C (2002). Human Peptide Deformylase (PDF, peptide deformylase (mitochondrial), GB2365433 published  20-Feb-2002 

 

[20] Cairns, W., Southan C.D., Huges S.A. & Duckworth  M (2002). Nuclear Hormone Receptor  Hepatocyte Nuclear Factor 4 gamma, (HNF4G,  hepatocyte nuclear factor 4, gamma)  WO0229046-A1, published 03-Jan-2002. AX403961

 

[19]  Southan C.D.& Hughes S.A. (2001) Matrix Metalloprotease MPROT45 (MMP28, matrix metallopeptidase 28), patent No. WO0155428, published 02-Aug-2001, AX206683      

 

[18] Southan, C.D., Palmer L.M, Zhu Y., & Li, X. (2000),  Metalloprotease  MPROT13 (OSGEP, O-sialoglycoprotein endopeptidase), patent No. WO0044913-A1 published 03-Aug-2000, AX033699

 

[17] Southan, C.D.(2000), Novel Compound (KLK4, kallikrein-related peptidase 4) patent No. WO0123587  published 05-Mar-2001, AX111692

 

[16] Southan, C.D., & Smith, T. (2000), Ubiquitin Specific Protease UPROT02 (USP21, ubiquitin specific peptidase 21), patent No. EP0972837-A2, published 19-Jan-2000, E39031  

 

[15*] Southan, C.D. & Evans J.R. (1999), Metalloprotease MPROT12 (ECEL1, endothelin converting enzyme-like 1  ), patent No. WO9957288-AI,  published 11-Nov-1999, AX011003,  granted as  United States Patent: 6255468  July-3-2001 

 

[14] Southan, C.D., & Smith, T. (1999), Serine Protease SPROT01 (LACTB, lactamase, beta  also the mouse orthologue Q9EP89 LACTB_MOUSE), patent No. WO9957286-A1,published 19-Dec-1999, AX011012 (human) and AX011007 (mouse)

 

[13] Southan, C.D., & Burgess, N. (1999), Metalloprotease MPROT15 (ACE2, angiotensin I converting enzyme (peptidyl-dipeptidase A) 2),  patent EP0974664, published 24-Nov-1999, E39033

 

[12] Evans J.R., Selzer, P.M. & Southan, C.D.,  (1999), Cysteine protease CPROT03 (TINAGL1, tubulointerstitial nephritis antigen-like 1), patent No.  WO9943831-A1, published 19-Sep-1999, AX018825, 

 

[11*] Southan, C.D., Burgess, N.& Chapman, C. (1999), Metalloprotease 02 (DNPEP, aspartyl aminopeptidase), patent No. EP0939131-A2, published  01-Sep-1999,  AX002999, 24-Aug-2000, granted as United States Patent: 6,180,384,  30-Jan-2001.

 

[10] Southan, C. D. (1999), Pancreatic polynucleotide and encoded protein, (PPY2,  pancreatic polypeptide 2)  patent No. EP0908515-A2, published 14-Apr-1999,  A97499, 26-Jan-2000.

 

[09*] Southan, C.D., Clinkenbeard, H. & Burgess, N. (1999), HE2NW40 (PRSS27, protease, serine 27), patent No. EP0890646-A2, published 13-Jan-1999, AX001350,  granted as United States Patent: 6,165,771, 26-Dec-2000.

 

[08*] Kristi, K, Knab, A, & Southan, C.D., (1998),  human RCE1 protease, (RCE1, RCE1 homolog, prenyl protein peptidase), patent No. EP0887414-A2, published 30-Dec-1998, AR108131, granted  as United States Patent: 6,110,717, 29-Aug-2000.

 

[07*] Kristi, K, Knab, A, & Southan, C.D., (1998),  human AFC1 protease, (ZMPSTE24, zinc metallopeptidase (STE24 homolog, S. cerevisiae)), patent No. EP0887416-A2, published 30-Dec-1998, E32056, granted as United States Patent: 6,060,277, 9-May-2000

 

[06*] Southan, C.D., Clinkenbeard H, & Burgess N (1998), HGBAB90/Serine Protease 8 (KLK8, kallikrein-related peptidase 8), patent No. EP887414-A2, published 30-Dec-1998, AX002035,  granted as United States Patent 6100059 08-Aug-2000.

 

[05*] Southan, C.D. Clinkenbeard, H. & Burgess, N. (1998), HTEGU07/Metalloprotease 9, (DPEP3, dipeptidase 3) , patent No. EP0881298-A2,published 30-Dec-1998. AX002250, granted as United States Patent: 6,090,583, 18-July 2000

 

[04*] Powell. D.J., Southan, C.D., & Chapman, C.G. (1998) Aspartic Proteinase ASP1 (BACE2, beta-site APP-cleaving enzyme 2),  patent No. EP0848062-A2, published 17-June-1998, AR136909, granted as  United States Patent: 6,025,180 15-Feb-2000

 

[03*] Karran, E.H., Clinkenbeard, H.E., Browne, M.J. & Southan, C.D., Creasy, C.L., Livi, G.P.(1998) Human Serine Protease/presenillin-associated protease-1 (HTRA2, HtrA serine peptidase 2), patent No. EP0828003-A2 published 11-Mar-1998,  AR095633,  granted as United States Patent: 6,004,794  21-Dec-1999

 

[02] Southan, C.D., (1997) Compound having sequence homology with lipoprotein associated Phospholipase A2 (Lp-PLA2) PAF Acetyl Hydrolase, claim for use as a therapeutic protein. (PAFAH2, platelet-activating factor acetylhydrolase 2, 40kDa) patent No. WO9712963-A2 published 10-Apr-1997, A61252,

 

[01*] Macphee C.H., Tew, D.G., Southan, C.D. & Hickey, D.M.B, (1995) Human T-cell lymphoma-associated lipoprotein associated Phospholipase A2.  (PLA2G7, phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)), patent No. WO9500649-A, published 5-Jan-1995, AX006795,  granted as EP0658205B1, 15-Mar-2000 and United States Patent: 7,045,329  16-May-2006.